Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/7/2025

Thyroid Hormone Replacement Therapy

Monitoring and Dose Adjustment

  • The American Association of Clinical Endocrinologists recommends monitoring TSH and free T4 after 6-8 weeks of the adjusted dose when changing thyroid medications 1
  • Target TSH should be within the reference range for most patients to prevent complications of both under and over-replacement 1
  • Patients with TSH <0.1 mIU/L have greater risk of complications than those with TSH between 0.1-0.45 mIU/L, including increased risk of atrial fibrillation and bone loss 2

Potential Pitfalls

  • Overreplacement with levothyroxine (indicated by suppressed TSH) increases risk of atrial fibrillation and bone loss, so careful dose titration is essential 2